REGENXBIO Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC RGNX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

654

Value ($000)

9

Weight

0.0%

2019 Q4 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	9	0.0%	654	12/31/2025
2024 Q4	2/14/2025	558	0.0%	72,183	12/31/2024
2024 Q3	11/14/2024	693	0.0%	66,078	9/30/2024
2024 Q2	8/14/2024	830	0.0%	70,958	6/30/2024
2024 Q1	5/15/2024	812	0.0%	38,544	3/31/2024
2023 Q4	2/14/2024	692	0.0%	38,544	12/31/2023
2023 Q3	11/13/2023	634	0.0%	38,544	9/30/2023
2023 Q2	8/11/2023	479	0.0%	25,307	6/30/2023
2023 Q1	5/15/2023	479	0.0%	25,307	3/31/2023
2022 Q4	2/14/2023	782	0.0%	34,498	12/31/2022
2022 Q3	11/14/2022	965	0.0%	36,495	9/30/2022
2022 Q2	8/12/2022	901	0.0%	36,495	6/30/2022
2022 Q1	5/16/2022	1,254	0.0%	37,790	3/31/2022
2021 Q4	2/14/2022	1,236	0.0%	37,790	12/31/2021
2021 Q3	11/15/2021	1,584	0.0%	37,790	9/30/2021
2021 Q2	8/16/2021	1,532	0.0%	39,443	6/30/2021
2021 Q1	5/14/2021	1,256	0.0%	36,831	3/31/2021
2020 Q4	3/1/2021	1,220	0.0%	26,890	12/31/2020
2020 Q3	11/13/2020	740	0.0%	26,890	9/30/2020
2020 Q2	8/14/2020	990	0.0%	26,890	6/30/2020
2020 Q1	5/15/2020	724	0.0%	22,365	3/31/2020
2019 Q4	2/14/2020	4,962	0.0%	121,124	12/31/2019